Joo JH, Sharma N, Shaia J, Wu AK, Skugor M, Singh RP, et al
Las mujeres en edad frtil deben saber que tirzepatida puede reducir la eficacia de los anticonceptivos orales, por lo que se recomienda un mtodo anticonceptivo adicional durante 4 semanas despus de iniciar el tratamiento o aumentar la dosis
If all goes according to plan, FDA approval should follow, and marketability by late 2026 or early 2027 could be possible, based on the timelines of other drugs in the category
S.G.B.F
The company says that the lots may be contaminated with diluted propylene glycol-based coolant from a machine leakage during the packaging process
Serious Risks and Contraindications While rare, GLP-1 medications carry risks that require medical supervision: Thyroid C-cell tumors - Animal studies showed an increased risk of medullary thyroid carcinoma in rodents